Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMPH · as of Jun 8, 2026
Key Statistics
Explore Amphastar Pharmaceuticals, Inc. Data
amph stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 25.0%
The AMPH analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $20.50, representing +3.85% upside from the current price of $19.74.
Competitors & Peers
amph competitorsAMPH
AHCO
BBNX
COLL
CVAC
DVAXStock Performance
Full HistoryAbout Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, …
what is amphastar pharmaceuticals, inc. · amph stock overview · amphastar pharmaceuticals, inc. company profile · who is amphastar pharmaceuticals, inc. ceo · amph NASDAQ · amphastar pharmaceuticals, inc. headquarters · amphastar pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Amphastar Pharmaceuticals, Inc. (AMPH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jun 25, 2014. As of the latest trading session, AMPH stock price is $19.74, with a market capitalization of $870.4M. The stock has returned -25.85% over the past 12 months and -26.29% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Amphastar Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $20.50. In fiscal year 2025, Amphastar Pharmaceuticals, Inc. reported revenue of $719.9M and net income of $98.1M. For detailed data — including Amphastar Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Amphastar Pharmaceuticals, Inc. (AMPH) stock price is $19.74. The stock is traded on NASDAQ under the ticker symbol AMPH. The 52-week range is $16.65 – $31.26.